Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000373895

Medchemexpress LLC Pritelivir mesylate | 1428333-96-3 | C19H22N4O6S3 | 5 MG
SDP

Catalog No. 5000373895
Encompass_Preferred

Pritelivir mesylate is an inhibitor of the viral helicase-primase complex, demonstrating antiviral activity both in vitro and in animal models of herpes simplex virus (HSV) infection. It is effective against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) with an IC50 of 0.02 μM. As the first in its class of antiviral agents, it inhibits HSV replication by targeting the viral helicase-primase enzyme complex.

  • Inhibits the viral helicase-primase complex.
  • Active against herpes simplex virus types 1 and 2.
  • Effective with an IC50 of 0.02 μM against HSV1-2.
  • Significantly increases survival and reduces mortality against HSV-1 and HSV-2 in animal models.
  • Exhibits potent and resistance-breaking antiviral efficacy.
  • Potential treatment for life-threatening HSV infections.

Catalog No. 50-003-73895 Supplier Medchemexpress LLC Supplier No. HY15303A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pritelivir mesylate is an inhibitor of the viral helicase-primase complex, demonstrating antiviral activity both in vitro and in animal models of herpes simplex virus (HSV) infection. It is effective against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) with an IC50 of 0.02 μM. As the first in its class of antiviral agents, it inhibits HSV replication by targeting the viral helicase-primase enzyme complex.

  • Inhibits the viral helicase-primase complex.
  • Active against herpes simplex virus types 1 and 2.
  • Effective with an IC50 of 0.02 μM against HSV1-2.
  • Significantly increases survival and reduces mortality against HSV-1 and HSV-2 in animal models.
  • Exhibits potent and resistance-breaking antiviral efficacy.
  • Potential treatment for life-threatening HSV infections.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.